Kai‐Feng Xu

104 papers and 1.5k indexed citations i.

About

Kai‐Feng Xu has authored 104 papers that have received a total of 1.5k indexed citations. This includes 65 papers in Pulmonary and Respiratory Medicine, 45 papers in Physiology and 17 papers in Molecular Biology. The topics of these papers are Tuberous Sclerosis Complex Research (35 papers), Neonatal Respiratory Health Research (17 papers) and Renal cell carcinoma treatment (15 papers). Kai‐Feng Xu is often cited by papers focused on Tuberous Sclerosis Complex Research (35 papers), Neonatal Respiratory Health Research (17 papers) and Renal cell carcinoma treatment (15 papers) and collaborates with scholars based in China, United States and Australia. Kai‐Feng Xu's co-authors include Xinlun Tian, Wenshuai Xu, Ruie Feng and Yanli Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Rankless by CCL
2025